Skip to Main Content

Paper Details

Tale of Two Erythropoiesis-Stimulating Agents: Utilization, Dosing, Litigation, and Costs of Darbepoetin and Epoetin Among South Carolina Medicaid-Covered Patients With Cancer and Chemotherapy-Induced Anemia.
J Oncol Pract
8
2017
CIA, Cancer, Chemotherapy, Darbepoetin, Epoetin, Patients, chemotherapy-induced anemia, darbepoetin, epoetin, patient, patients
Author NameAffiliation
Zaina P QureshiUniversity of South Carolina William Jennings Bryan Dorn Veterans Affairs Medical Center, Columbia Hollings Cancer Center, Medical University of South Carolina, SC George Mason University, VA and Medical Technology and Practice Patterns Institute
Benjamin SchooleyUniversity of South Carolina William Jennings Bryan Dorn Veterans Affairs Medical Center, Columbia Hollings Cancer Center, Medical University of South Carolina, SC George Mason University, VA and Medical Technology and Practice Patterns Institute
Paul R YarnoldUniversity of South Carolina William Jennings Bryan Dorn Veterans Affairs Medical Center, Columbia Hollings Cancer Center, Medical University of South Carolina, SC George Mason University, VA and Medical Technology and Practice Patterns Institute
Charles L BennettUniversity of South Carolina William Jennings Bryan Dorn Veterans Affairs Medical Center, Columbia Hollings Cancer Center, Medical University of South Carolina, SC George Mason University, VA and Medical Technology and Practice Patterns Institute
Charles L BennettUniversity of South Carolina William Jennings Bryan Dorn Veterans Affairs Medical Center, Columbia Hollings Cancer Center, Medical University of South Carolina, SC George Mason University, VA and Medical Technology and Practice Patterns Institute
  • 1 - 5

Datasets

Release 1.2